Published in Neurology on April 12, 2005
Early-onset Lafora body disease. Brain (2012) 1.01
Lafora disease, seizures and sugars. Acta Myol (2007) 1.00
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci (1998) 2.09
Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev (2001) 2.07
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain (2008) 1.70
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology (2007) 1.53
Study of physiological availability of temazepam in man. Int J Clin Pharmacol (1972) 1.49
Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology (2006) 1.48
Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl (1999) 1.27
Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet (2000) 1.27
High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum Reprod (1998) 1.20
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology (2004) 1.17
Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology (2007) 1.14
Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis (2013) 1.08
Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting. Pediatr Neurol (2000) 1.07
ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther (1997) 1.05
Human male infertility and Y chromosome deletions: role of the AZF-candidate genes DAZ, RBM and DFFRY. Hum Reprod (1999) 1.04
The human Y chromosome's azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men. J Med Genet (2003) 1.04
Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol (2000) 1.04
Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet (2003) 1.04
Zolpidem in progressive supranuclear palsy. N Engl J Med (1999) 1.02
Lafora disease, seizures and sugars. Acta Myol (2007) 1.00
H2(15)O or 13NH3 PET and electromagnetic tomography (LORETA) during partial status epilepticus. Neurology (2005) 1.00
Pallidal deep brain stimulation in cervical dystonia: clinical outcome in four cases. Can J Neurol Sci (2004) 0.99
Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology (2002) 0.98
Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain (2010) 0.98
Prognostic value of Y deletion analysis. The role of current methods. Hum Reprod (2001) 0.98
Y chromosome microdeletions in cryptorchidism and idiopathic infertility. J Clin Endocrinol Metab (1999) 0.96
Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD. Parkinsonism Relat Disord (2012) 0.95
Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology (2000) 0.95
Model of frequent, recurrent, and spontaneous seizures in the intact mouse hippocampus. Hippocampus (2004) 0.94
Autoinduction of rifabutin metabolism in man. Xenobiotica (1990) 0.93
Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology (2003) 0.92
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology (2007) 0.91
Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer (2000) 0.89
Interobserver and echo-angio variability of two-dimensional colour Doppler evaluation of aortic and mitral regurgitation. Eur Heart J (1989) 0.89
Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man. Eur J Clin Pharmacol (1973) 0.89
Multisensory determinants of orientation perception in Parkinson's disease. Neuroscience (2010) 0.89
Feasibility and variability of six methods for the echocardiographic and Doppler determination of cardiac output. Br Heart J (1988) 0.88
Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels. Ann Oncol (2008) 0.87
Changes in motor cortex excitability with stimulation of anterior thalamus in epilepsy. Neurology (2006) 0.87
X-linked vacuolar myopathies: two separate loci and refined genetic mapping. Ann Neurol (2000) 0.86
Bioavailability and pharmacokinetics in man of acipimox, a new antilipolytic and hypolipemic agent. J Int Med Res (1981) 0.86
Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology (2004) 0.85
Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol (1996) 0.85
Pharmacokinetic studies of indoprofen in healthy volunteers and in patients. Int J Clin Pharmacol Biopharm (1977) 0.84
Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma. Am J Clin Oncol (2002) 0.84
Reduced paired pulse depression in the basal ganglia of dystonia patients. Neurobiol Dis (2012) 0.84
Parental imprinting and Angelman syndrome. Adv Neurol (1999) 0.84
Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man. Eur J Clin Pharmacol (1979) 0.84
Pharmacokinetics of the enantiomers of indoprofen in man. Int J Clin Pharmacol Res (1984) 0.83
Changes in cortical excitability with thalamic deep brain stimulation. Neurology (2005) 0.83
Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery. J Neurol Neurosurg Psychiatry (2005) 0.83
Role of the AZFa candidate genes in male infertility. J Endocrinol Invest (2000) 0.82
Y-chromosomal DNA haplotypes in infertile European males carrying Y-microdeletions. J Endocrinol Invest (2000) 0.82
Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis. Scand J Rheumatol (1980) 0.82
Absence of testicular DAZ gene expression in idiopathic severe testiculopathies. Hum Reprod (1999) 0.81
Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization. Clin Exp Allergy (2008) 0.81
[Ovarian cancer in a female patient with von Recklinghausen's disease]. Med Clin (Barc) (1991) 0.81
Clinical and MRI evidence that occipital lobe seizures can be the major manifestation of the reversible posterior leukoencephalopathy syndrome (RPLS) Epilepsia (1998) 0.81
Identification of genomic deletions spanning the PCDH19 gene in two unrelated girls with intellectual disability and seizures. Clin Genet (2011) 0.80
Estimation of coupling between oscillators from short time series via phase dynamics modeling: limitations and application to EEG data. Chaos (2005) 0.80
Evidence for FSH-dependent upregulation of SPATA2 (spermatogenesis-associated protein 2). Biochem Biophys Res Commun (2001) 0.80
Sertoli cell function in infertile patients with and without microdeletions of the azoospermia factors on the Y chromosome long arm. J Clin Endocrinol Metab (2001) 0.80
Update in the management of ovarian and cervical carcinoma. Clin Transl Oncol (2007) 0.80
Role of neuronal and inducible nitric oxide synthases in the guinea pig ileum myenteric plexus during in vitro ischemia and reperfusion. Neurogastroenterol Motil (2013) 0.80
Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J Med Genet (2006) 0.80
GLC determination of plasma levels of enantiomers of alpha-(4-(1-oxo-2-isoindolinyl)phenyl)propionic acid. J Pharm Sci (1974) 0.79
Acute challenge with apomorphine and levodopa in Parkinsonism. Eur Neurol (2000) 0.79
Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colon. Neurogastroenterol Motil (2001) 0.79
Pharmacokinetics and bioavailability of metergoline in healthy volunteers after single i.v. and oral administration. Int J Clin Pharmacol Res (1983) 0.79
Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm (1989) 0.79
Prominent 5-18 Hz oscillations in the pallidal-thalamic circuit in secondary dystonia. Neurology (2012) 0.79
31Phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumors. Int J Radiat Oncol Biol Phys (1998) 0.79
Y chromosome. Lancet (2000) 0.79
Impulse control disorders and subthalamic nucleus stimulation in Parkinson's disease: are we jumping the gun? Eur J Neurol (2009) 0.78
Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose. Eur J Clin Pharmacol (1989) 0.78
Fine-mapping the gene for X-linked myopathy with excessive autophagy. Neurology (2008) 0.78
Protein kinase C modulates NMDA receptors in the myenteric plexus of the guinea pig ileum during in vitro ischemia and reperfusion. Neurogastroenterol Motil (2010) 0.78
A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. J Endocrinol Invest (2002) 0.78
[Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. Ann Ital Med Int (2001) 0.78
A writing device improves writing in primary writing tremor. Neurology (2005) 0.78
Mitomycin-C and vinblastine in advanced breast cancer. Oncology (1989) 0.78
Gastric motor effects of triptans: open questions and future perspectives. Pharmacol Res (2001) 0.77
Novel insulin-like 3 (INSL3) gene mutation associated with human cryptorchidism. Am J Med Genet (2001) 0.77
Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second-third line erlotinib. Lung Cancer (2009) 0.77
Clinical genetic study of familial Parkinson's disease in Italy. Adv Neurol (1999) 0.77
Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J Med Genet (2007) 0.76
Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients. Int J Clin Pharmacol Res (1984) 0.76
Lafora bodies in skeletal muscle are fiber type specific. Neurology (2011) 0.76
Long-term ventralis intermedius thalamic stimulation for parkinsonian tremor. Italian Registry for Neuromodulation in Movement Disorders. Adv Neurol (1999) 0.75
Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy. Mov Disord (2000) 0.75
Anaerobes: a new aetiology in cavitary pneumoconiosis. Br J Ind Med (1982) 0.75
Minimal change glomerular disease in association with a carcinoma of the esophagus. Nephron (1994) 0.75
Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygosities. Am J Hum Genet (1997) 0.75
Lafora disease: a case report, pathologic and genetic study. Indian J Pathol Microbiol (2011) 0.75